Last weekend, the kick-off meeting of the National Center for Traumatology-Macau Fok Ying Tung Foundation PTSD Project was held at the National Trauma Medical Center of Peking University People's Hospital, which will help establish PTSD diagnosis and treatment standards for trauma patients in China.
The reporter learned from the District Economic and Information Bureau that the pharmaceutical and health industry of the sub-center achieved a total output value of 12.36 billion yuan last year, with an average annual growth rate of 14% in the past five years.
Post-traumatic stress disorder (PTSD) is a far-reaching mental illness that affects not only the daily life of individuals, but also the healthy functioning of society, regardless of national borders, ethnicity or social class.
According to reports, the central clinical research project on the current situation, mechanism and intervention of PTSD in Chinese trauma patients is committed to understanding the occurrence, development and prognosis of PTSD in Chinese trauma patients. Establishment of the China Trauma PTSD Data Center. The influencing factors of PTSD were discussed, and finally the diagnosis and treatment standards of PTSD in trauma patients in China were established.
This time, the Fok Ying Tung Foundation of Macau funded 10 million yuan for the research fund of Peking University People's Hospital.
The aim of this study aims to systematically carry out the first large-scale PTSD diagnosis and treatment study in China through the National Trauma Medical Center of Peking University People's Hospital to gain an in-depth understanding of the etiology, development mechanism and effective intervention and treatment methods of PTSD through basic clinical research, database building, and multidisciplinary research methods, so as to provide help for improving the quality of life of trauma patients and improving the level of diagnosis and treatment.
In the future, the Fok Ying Tung Foundation will join hands with the research team led by Professor Wang Tianbing from Peking University People's Hospital to establish this project in Beijing, strengthen international cooperation, and join hands with world-renowned psychologists, doctors and social workers to participate. It also supports research and innovation in PTSD, including the development of new treatments, drugs and psychological interventions to provide more personalized and effective treatments.
As the only trauma center in China, the National Trauma Medical Center has been leading the construction of trauma system, clinical treatment and related research in China, especially the diagnosis and treatment of multiple injuries, severe trauma, hemorrhagic shock, and multiple organ injuries caused by traffic and fall high energy, which is close to the treatment level of developed countries in Europe and the United States.
Severe traumatic multiple injuries not only cause structural injuries to the body, but also have a serious psychological and mental impact on patients. This research project is the first systematic study of PTSD in China, which will provide comprehensive, systematic and scientific intervention for trauma patients while their bodies can be well treated.
The reporter learned from the District Economic and Information Bureau that the sub-center of the city has always adhered to a high starting point planning, high-standard construction, and high-quality development, and the head resources and innovative elements of various industries have been prioritized to achieve the layout. Focusing on the "3+1" leading functions of administrative office, business services, cultural tourism, and scientific and technological innovation, the sub-center is cultivating and expanding six industrial clusters of digital economy, modern finance, advanced manufacturing, business services, cultural tourism, and modern seed industry, seizing the development opportunities of future information, future health, future energy and other industries, and striving to promote the high-quality development of the sub-center with new quality productivity.
Especially in the field of medicine and health, the sub-center is making every effort to build a demonstration area for medical-industrial collaboration.
In 2023, the pharmaceutical and health industry of the sub-center will achieve a total output value of 12.36 billion yuan, with an average annual growth rate of 14% in the past five years. At present, the sub-center has registered a total of 493 market entities in the field of medicine and health, including 5 listed companies, 5 national small giant enterprises, 1 national enterprise technology center and 1 individual champion enterprise. At the same time, Gan & Lee, Fuyuan, Chunli and other leading enterprises in the industry have a significant driving effect.
Peking University People's Hospital, as the only hospital under the jurisdiction of the National Health Commission introduced by the sub-center, has made contributions to regional medical construction, transformation of scientific research achievements, and coordinated development of medical industry, and has taken the lead in establishing the first medical-industrial collaborative innovation base of the sub-center and the Beijing-Tianjin-Hebei Medical Consortium Alliance. Since its opening more than two years ago, the hospital has provided a broad development platform for promoting the coordinated development of medical and industrial development in the sub-center.
Relying on the resources and technical advantages of the National Trauma Medical Center, the hospital launched the first large-scale diagnosis and treatment research in the field of PTSD in China, and will carry out basic research on the mechanism of PTSD based on special data sets, and is expected to establish the diagnosis and treatment standards of PTSD for acute trauma in China, so as to further consolidate the authoritative diagnosis and treatment service level of the hospital in the field of trauma, and contribute to the construction of a healthy China and the improvement of people's health and well-being.
The sub-center will also integrate high-quality industrial resources to provide service support for the scientific research innovation and achievement transformation of the institute.
In the future, the sub-center will improve the service system, improve the supporting elements, enhance the industrial level, expand and enrich the "medical industry" resources in the region, accelerate the construction of the "medical and industrial collaboration demonstration zone", and show new responsibilities and achieve new achievements in the high-quality development of the capital's medical and health industry.
The content comes from Beijing City Sub-Center Daily reporter Zhao Peng and Guo Lijun
Correspondent Kim Jong-hak
Edited by Xu Qing